Todd Harris - Mar 14, 2025 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
President and CEO, Director
Signature
/s/ Ali D. Fawaz, Attorney-in-Fact
Stock symbol
TYRA
Transactions as of
Mar 14, 2025
Transactions value $
$12,131
Form type
4
Date filed
3/18/2025, 06:44 PM
Previous filing
Oct 22, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Award $12.1K +1.24K +0.09% $9.78 1.36M Mar 14, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.